RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Get ready for more merger mania in the pharma sector It means that with each new approval, another 12 years is added to the life of the drug, for an indefinte period of time. Consequently, the only way the product could be "time-bound" is when no futher new indications are approved ... and that could be several decades from now.